Relay Therapeutics, Inc. · NASDAQ:RLAY
Catinazzo Thomas sold 1,469 Relay Therapeutics, Inc. shares (Form 4)
Traded Oct 28, 2026 · Filed Oct 30, 2026
On Oct 28, 2026, Catinazzo Thomas (Chief Financial Officer) sold 1,469 Relay Therapeutics, Inc. shares at US$18.62 for US$27,353, leaving 103,665 shares. Filed Oct 30, 2026 (Form 4).
- Sold
- 1,469 shares
- Price
- US$18.62
- Value
- US$27,353
- Holding after
- 103,665 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 28, 2026 | Common Stock | Sale | 1,469 | US$18.62 | 103,665 | Direct |
Source
Download original · View original at SEC
Related
- Relay Therapeutics, Inc.
- Catinazzo Thomas
- Relay Therapeutics, Inc. shareholders
- Form 4 · Catinazzo Thomas · Nov 20, 2026
- Form 4 · Catinazzo Thomas · Oct 8, 2026
- Form 4 · Catinazzo Thomas · Sep 9, 2026
- Form 4 · Catinazzo Thomas · Aug 18, 2026
- Form 4 · Catinazzo Thomas · Jul 30, 2026
- Form 4 · Patel Sanjiv · Nov 20, 2026
- Form 4 · Bergstrom Donald A · Nov 20, 2026
- Schedule 13G · T. Rowe Price Investment Management, Inc. · Nov 16, 2026
- Schedule 13G/A · Sb Investment Advisers (UK) LTD · Nov 16, 2026
- Form 4 · Rahmer Peter · Oct 30, 2026